Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 tesla

Journal of Computer Assisted Tomography

Volumn 34, Issue 3, 2010, Pages 372-376

  Bredella, Miriam A ^a   Ghomi, Reza Hosseini ^a   Thomas, Bijoy J ^a   Ouellette, Hugue A ^a   Sahani, Dushyant V ^a   Miller, Karen K ^a   Torriani, Martin ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Lipids; Liver; MR spectroscopy

Indexed keywords

COMPUTERIZED TOMOGRAPHY; CORRELATION METHODS; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY;

1H MAGNETIC RESONANCE SPECTROSCOPIES; BREATH-HOLD; CORRELATION COEFFICIENT; LIPID CONTENT; LIPID QUANTIFICATIONS; MR SPECTROSCOPY; PEARSON CORRELATION COEFFICIENTS; PREMENOPAUSAL WOMEN; SINGLE VOXEL; STRONG CORRELATION;

INVERSE PROBLEMS;

ADULT; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; LIPID ANALYSIS; LIVER LEVEL; PREMENOPAUSE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE STUDY; RELIABILITY; REPRODUCIBILITY;

EID: 77952983244     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181cefb89     Document Type: Article

References (36)

1. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:1843-1848.
2. Zhang C, Rexrode KM, van Dam RM, et al. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117:1658-1667.
3. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134-140.
4. Falck-Ytter Y, Younossi ZM, Marchesini G, et al. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21:17-26.
5. Lall CG, Aisen AM, Bansal N, et al. Nonalcoholic fatty liver disease. AJR Am J Roentgenol. 2008;190:993-1002.
6. Cassidy FH, Yokoo T, Aganovic L, et al. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics. 2009;29:231-260.
7. Cowin GJ, Jonsson JR, Bauer JD, et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging. 2008;28:937-945.
8. Guiu B, Loffroy R, Petit JM, et al. Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy. Eur Radiol. 2009;19:1786-1793.
9. Guiu B, Petit JM, Loffroy R, et al. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology. 2009;250:95-102.
10. Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol. 2007;188:1307-1312.
11. Machann J, Thamer C, Schnoedt B, et al. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med. 2006;55:913-917.
12. Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108-113.
13. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging. 1995;5:281-285.
14. Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol. 1999; 276: E977-E989.
15. Fischbach F, Bruhn H. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review. Liver Int. 2008;28:297-307.
16. Hadigan C, Liebau J, Andersen R, et al. Magnetic resonance spectroscopy of hepatic lipid content and associated risk factors in HIV infection. J Acquir Immune Defic Syndr. 2007;46:312-317.
17. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005; 288: E462-E468.
18. van Werven JR, Hoogduin JM, Nederveen AJ, et al. Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content. J Magn Reson Imaging. 2009;30:444-448.
19. Kim H, Taksali SE, Dufour S, et al. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point Dixon and three-point IDEAL. Magn Reson Med. 2008;59:521-527.
20. Noworolski SM, Tien PC, Merriman R, et al. Respiratory motion-corrected proton magnetic resonance spectroscopy of the liver. Magn Reson Imaging. 2009;27:570-576.
21. Pfleiderer B, Xu P, Ackerman JL, Garrido L. Study of aging of silicone rubber biomaterials with NMR. J Biomed Mater Res. 1995;29:1129-1140.
22. Star-Lack JM, Adalsteinsson E, Gold GE, et al. Motion correction and lipid suppression for 1H magnetic resonance spectroscopy. Magn Reson Med. 2000;43:325-330.
23. Bredella MA, Torriani M, Thomas BJ, et al. Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J Clin Endocrinol Metab. 2009;94:3995-4002.
24. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672-679.
25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
26. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255-268.
27. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388-1393.
28. Federico A, Niosi M, Vecchio Blanco CD, et al. Emerging drugs for non-alcoholic fatty liver disease. Expert Opin Emerg Drugs. 2008;13:145-158.
29. Huang MA, Greenson JK, Chao C, et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol. 2005;100:1072-1081.
30. Limanond P, Raman SS, Lassman C, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology. 2004;230:276-280.
31. Johnson NA, Walton DW, Sachinwalla T, et al. Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology. 2008;47:1513-1523.
32. Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut. 2005;54:122-127.
33. Tyszka JM, Silverman JM. Navigated single-voxel proton spectroscopy of the human liver. Magn Reson Med. 1998;39:1-5.
34. Pineda N, Sharma P, Xu Q, et al. Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy-a rapid and accurate technique. Radiology. 2009;252:568-576.
35. Sharma P, Martin DR, Pineda N, et al. Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction. J Magn Reson Imaging. 2009;29:629-635.
36. de Bazelaire CM, Duhamel GD, Rofsky NM, et al. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology. 2004;230:652-659.